George Mark, MD
Clinical Cardiac Electrophysiology · Haddon Heights, NJNPI 1265516488
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Boston Scientific at 42.5% of the total. Reporting peaked in 2019 at $100,952 and has fallen 65.8% since, to $34,512 in 2024. Among clinical cardiac electrophysiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,097 payments — averaging $284.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$133K
- Abbott$82K
- Impulse Dynamics (USA) Inc.$40K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$29K
- E.r. Squibb & Sons, L.L.C.$12K
- Biotronik Inc.$4K
- plus $13K from 32 others
Across 244 payments — averaging $2551.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$395K
- Janssen Research & Development, LLC$146K
- Biosense Webster, Inc.$39K
- Abbott$26K
- Impulse Dynamics (USA) Inc.$13K
- Biotronik Inc.$4K
What the payments were for
- Consulting fees$98,47532%
- Speaking & faculty fees$140,86845%
- Travel & lodging$42,81814%
- Food & beverage$29,0999%
- Education$5820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 200 | $132,581 |
| Abbott | 437 | $81,659 |
| Impulse Dynamics (USA) Inc. | 83 | $40,031 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 72 | $29,307 |
| E.r. Squibb & Sons, L.L.C. | 31 | $11,702 |
| Biotronik Inc. | 51 | $3,861 |
| Biosense Webster, Inc. | 43 | $3,747 |
| Pfizer | 24 | $3,174 |
| Medical Device Business Services, Inc. | 2 | $2,275 |
| Atricure, Inc. | 16 | $805 |
| Johnson & Johnson(2 entities) | 39 | $474 |
| Cvrx, Inc. | 11 | $457 |
| Medtronic(2 entities) | 9 | $230 |
| Amgen | 15 | $217 |
| Philips North America LLC | 2 | $176 |
| Novartis | 8 | $129 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Merck | 6 | $86 |
| Cardiva Medical, Inc. | 3 | $75 |
| Elutia, Inc. | 4 | $74 |
| Boehringer Ingelheim | 5 | $71 |
| Sanofi-aventis U.S. LLC | 5 | $67 |
| Volta Medical Inc | 1 | $63 |
| W. L. Gore & Associates, Inc. | 3 | $55 |
| Amarin Pharma, Inc. | 4 | $53 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 3 | $45 |
| Altathera Pharmaceuticals LLC | 2 | $43 |
| AstraZeneca | 3 | $43 |
| Chiesi USA, Inc. | 2 | $36 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $28 |
| Edwards Lifesciences | 1 | $22 |
| Regeneron | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk | 1 | $13 |
| Acarix USA Inc. | 1 | $13 |
| Preventice Services, LLC | 1 | $13 |
| Lundbeck LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$55,929
- OPTIMIZER$55,204
- AMPLATZER AMULET$42,988
- LifeVest$28,500
- GENERAL - THERAPIES$24,548
- WATCHMAN Access System$18,260
- ELIQUIS$13,530
- Ensite Cardiac Mapping System$11,650
- WATCHMAN FLX$11,125
- CLINICAL TRIAL PRODUCT$7,800
- OPTIMIZER SMART SYSTEM$5,655
- AMPLATZER$4,231
- Carto 3 System$3,500
- EnSite Precision Cardiac Mapping System$2,504
- AVEIR$2,409
- ENSITE PRECISION$2,363
- EMBLEM$2,175
- Confirm Rx$1,921
- Anthem CRT Pacemaker$1,900
- Carto 3$1,496
How this compares
$311,841 in reported general payments places this provider in the 95th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 307 | $353,773 |
| XareltoRivaroxaban | 51 | $71,539 |
| EntrestoSacubitril/Valsartan | 18 | $14,911 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 21 | $8,194 |
| BrilintaTicagrelor | 12 | $5,498 |
| Flecainide Acetate | 91 | $3,469 |
| Metoprolol Succinate | 145 | $2,339 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 34 | $1,738 |
| Amiodarone Hcl | 29 | $1,125 |
| Metoprolol Tartrate | 84 | $893 |
| Atorvastatin Calcium | 84 | $689 |
| Carvedilol | 56 | $509 |
| Amlodipine Besylate | 45 | $497 |
| Valsartan | 19 | $454 |
| ClopidogrelClopidogrel Bisulfate | 35 | $446 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $3,174 | $353,773307 claims |
| Johnson & JohnsonXarelto | $474 | $71,53951 claims |
| NovartisEntresto | $129 | $14,91118 claims |
| AstraZenecaBrilinta | $43 | $5,49812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Haddon Heights
- Steven LeviHaddon Heights$43K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Grant SimonsEnglewood$93K
- Jonathan SteinbergRidgewood$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.